NCT02351115View on ClinicalTrials.gov

Staccato Alprazolam and Photoparoxysmal Response

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Epilepsy
Interventions
DRUG

A=Placebo

DRUG

B=Inhaled Alprazolam 0.5 mg

DRUG

C=Inhaled Alprazolam 1 m

DRUG

D= Inhaled Alprazolam 2 mg

DRUG

E=Placebo

Trial Locations (3)

Unknown

Consultants in Epilepsy & Neurology, PLLC, Boise

New York University Epilepsy Center, New York

University of Pennsylvania - Penn Epilepsy Center, Philadelphia

Sponsors
All Listed Sponsors
collaborator

The Epilepsy Study Consortium

OTHER

lead

Alexza Pharmaceuticals, Inc.

INDUSTRY